FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 194 filers reported holding FIBROGEN INC in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $14,836,000 | -5.1% | 400,000 | +5.3% | 0.32% | -16.1% |
| Q3 2020 | $15,626,000 | -3.6% | 380,000 | -5.0% | 0.38% | -16.5% |
| Q2 2020 | $16,212,000 | -22.2% | 400,000 | -33.3% | 0.45% | -48.5% |
| Q1 2020 | $20,850,000 | +21.5% | 600,000 | +50.0% | 0.88% | +32.9% |
| Q4 2019 | $17,156,000 | +157.8% | 400,000 | +122.2% | 0.66% | +148.3% |
| Q3 2019 | $6,656,000 | -18.2% | 180,000 | 0.0% | 0.27% | -18.8% |
| Q2 2019 | $8,132,000 | -25.2% | 180,000 | -10.0% | 0.33% | -25.9% |
| Q1 2019 | $10,870,000 | -47.8% | 200,000 | -55.6% | 0.44% | -42.4% |
| Q4 2018 | $20,826,000 | +37.1% | 450,000 | +80.0% | 0.77% | +95.2% |
| Q3 2018 | $15,188,000 | -3.0% | 250,000 | 0.0% | 0.40% | +18.6% |
| Q2 2018 | $15,650,000 | +35.5% | 250,000 | 0.0% | 0.33% | +129.7% |
| Q1 2018 | $11,550,000 | +329.4% | 250,000 | +400.0% | 0.14% | +215.2% |
| Q3 2017 | $2,690,000 | – | 50,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |